APVO
Aptevo Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.42
-0.15 ▼ -3.28%
🌙 3월 13일 6:27 PM ET (한국 3/14 07:27)
$4.50
+0.08 ▲ +1.81%
| Index | - | P/E | - | EPS (ttm) | -3331.19 | Insider Own | 0.08% | Shs Outstand | 0.00B | Perf Week | -30.94% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 70.21% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -36.4% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -8.09 | Inst Own | 4.2% | Short Float | 11.68% | Perf Quarter | -79.54% |
| Income | -0.03B | P/S | - | EPS this Y | 99.69% | Inst Trans | - | Short Ratio | 0.61 | Perf Half Y | -83.63% |
| Sales | 0.00B | P/B | 0.19 | EPS next 5Y | 90.39% | ROA | -132.66% | Short Interest | 0.12M | Perf YTD | -53.13% |
| Book/sh | 22.67 | P/C | 0.21 | EPS past 3/5Y | 79.32% 80.96% | ROE | -256.3% | 52W High | -99.66% ($1299.60) | Perf Year | -99.48% |
| Cash/sh | 21.11 | P/FCF | - | Sales past 3/5Y | - | ROIC | -130.73% | 52W Low | 11.9% ($3.95) | Perf 3Y | -100% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 99.02% | Gross Margin | - | Volatility(W/M) | 13.99% 9.23% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.66 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.03 | EPS Q/Q | 99.38% | Profit Margin | - | RSI (14) | 27.47 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.03 | Sales Q/Q | - | SMA20 | -30.88% ($6.39) | Beta | 1.48 | Target Price | $378 |
| Payout | - | Debt/Eq | 0.23 | Earnings | 11000000 | SMA50 | -40.83% ($7.47) | Rel Volume | 0.18 | Prev Close | $4.57 |
| Employees | 42 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | -6.7% - | SMA200 | -85.74% ($31) | Avg Volume(3M) | 0.19M | Price | $4.42 |
| IPO | 2016/7/20 | Option/Short | No/Yes | Trades | 1035 | Volume | 33,765 | Change | -3.28% |
뉴스 로딩 중...